Abstract
An important parameter in the development of pharmacokinetic models is the ratio of tissue drug concentration to the concentration of the drug in the arterial plasma or the effluent plasma. The relationship between these two tissue/plasma ratios is derived analytically for different routes of drug administration. The two are equal only in compartments with no elimination when the drug is infused at constant rate. For other routes of administration, the two ratios are identical in all compartments only when there is no elimination process. The tissue/plasma concentration ratios for infusion equilibrium are not equal to the corresponding values for the postdistribution phase after an intravenous bolus injection. When the plasma concentration for infusion and injection are the same, more drug will appear in the lung during infusion steady state than during the postdistribution equilibrium. The reverse is true for the other organs. The importance of properly defining the tissue/plasma ratio and its implication for pharmacokinetic modeling are discussed. The results may have important therapeutic implications for the availability of drugs using different routes of administration.
Similar content being viewed by others
References
K. B. Bischoff and R. G. Brown. Drug distribution in mammals.Chem. Eng. Drug. Symp. Ser. 62(66):32–45 (1966).
K. B. Bischoff. Applications of a mathematical model for drug distribution in mammals. In D. Hershey (ed.),Chemical Engineering in Medicine and Biology, Plenum, New York, 1967, pp. 417–446.
K. B. Bischoff and R. L. Dedrick. Thiopental pharmacokinetics.J. Pharm. Sci. 57:1346–1351 (1968).
K. B. Bischoff, R. L. Dedrick, and D. S. Zaharko. Preliminary model for methotrexate pharmacokinetics.J. Pharm. Sci. 59:149–154 (1970).
K. B. Bischoff, R. L. Dedrick, D. S. Zaharko, and J. A. Longstreth. Methotrexate pharmacokinetics.J. Pharm. Sci. 60:1128–1133 (1971).
R. L. Dedrick, D. D. Forrester, and D. H. W. Ho. In-vitro-In-vivo correlation of drug metabolism-Determination of 1-Β-D-arabinsfurenosylcytosine.Biochem. Pharmacol. 21:1–16 (1972).
N. Benowitz, R. P. Forsyth, K. L. Melman, and M. Rowland. Lidocaine disposition kinetics in monkey and man. I. Predicted by a perfusion model.Clin. Pharmacol. Ther. 16:87–98 (1974).
N. Benowitz, R. P. Forsyth, K. L. Melman, and M. Rowland. Lidocaine disposition kinetics in monkey and man. II. Effects of hemorrhage and sympathomimetic drug administration.Clin. Pharmacol. Ther. 16:99–109 (1974).
B. Montandon, R. J. Roberts, and L. J. Fisher. Computer simulation of sulfobromophthalein kinetics in the rat using flow-limited models with extrapolation to man.J. Pharmacokin. Biopharm. 3:277–290 (1975).
P. A. Harris and J. F. Gross. Preliminary pharmacokinetics model for adriamycin (NSC-123127).Cancer Chemother. Rep. Part I 59:819–825 (1975).
L. I. Harrison and M. Gibaldi. Physiologically based pharmacokinetic model for digoxin distribution and elimination in the rat.J. Pharm. Sci. 66:1138–1142 (1977).
L. I. Harrison and M. Gibaldi. Physiologically based pharmacokinetic model for digoxin distribution in dogs and its preliminary application to humans.J. Pharm. Sci. 66:1679–1683 (1977).
K. J. Himmelstein and J. F. Gross. Mathematical model for cyclocytidine pharmacokinetics.J. Pharm. Sci. 66:1441–1444 (1977).
C. N. Chen, D. L. Coleman, J. D. Andrade, and A. R. Temple. Pharmacokinetic model for salicylate in cerebrospinal fluid, blood, organs and tissues.J. Pharm. Sci. 67:38–45 (1978).
R. L. Dedrick. Animal scale-up.J. Pharmacokin. Biopharm. 1:435–461 (1978).
K. Uchida and W. Kreis. Studies on drug resistance. I. Distribution of 1-Β-D-arabinofuranosylcytosine, cytidine and deoxycytidine in mice bearing Ara-C-sensitive and -resistant P815 neoplasms.Biochem. Pharmacol. 18:1115–1128 (1969).
G. L. Neil, T. E. Moxley, and R. C. Manak. Enhancement by tetrahydrouridine of 1-Β-D-arabinofuranosylcytosine (cytarabine) oral activity in L1210 leukemic mice.Cancer Res. 30:2166–2172 (1970).
M. Gibaldi. Effect of mode of administration on drug distribution in a two-compartment open system.J. Pharm. Sci. 58:327–331 (1969).
R. J. Lutz, W. M. Galbraith, R. L. Dedrick, R. Shrager, and L. B. Mellett. A model for the kinetics of distribution of actinomycin-D in the beagle dog.J. Pharmacol. Exp. Ther. 200:469–478 (1977).
Author information
Authors and Affiliations
Additional information
This work was supported by Grant CA-17094 from the National Cancer Institute.
Rights and permissions
About this article
Cite this article
Chen, H.S.G., Gross, J.F. Estimation of tissue-to-plasma partition coefficients used in physiological pharmacokinetic models. Journal of Pharmacokinetics and Biopharmaceutics 7, 117–125 (1979). https://doi.org/10.1007/BF01059446
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01059446